Ardavan Abiri

820 total citations
29 papers, 615 citations indexed

About

Ardavan Abiri is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Ardavan Abiri has authored 29 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Organic Chemistry and 6 papers in Computational Theory and Mathematics. Recurrent topics in Ardavan Abiri's work include Computational Drug Discovery Methods (6 papers), Synthesis and biological activity (5 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Ardavan Abiri is often cited by papers focused on Computational Drug Discovery Methods (6 papers), Synthesis and biological activity (5 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Ardavan Abiri collaborates with scholars based in Iran, United States and Malaysia. Ardavan Abiri's co-authors include Ashkan Safavi, Amirhosein Kefayat, Fatemeh Ghahremani, Yaghoub Pourshojaei, Ali Asadipour, Khalil Eskandari, Najmeh Edraki, Zahra Haghighijoo, Hamid Reza Rahimi and Marc Lavigne and has published in prestigious journals such as PLoS ONE, Analytical Biochemistry and Scientific Reports.

In The Last Decade

Ardavan Abiri

28 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ardavan Abiri Iran 12 404 109 105 105 98 29 615
Noor Rahman Pakistan 11 279 0.7× 63 0.6× 139 1.3× 60 0.6× 30 0.3× 26 522
Qingbo Liu China 14 299 0.7× 116 1.1× 109 1.0× 60 0.6× 42 0.4× 43 616
Muhammad Junaid China 18 512 1.3× 80 0.7× 236 2.2× 78 0.7× 35 0.4× 34 760
Priyanka Shah India 17 265 0.7× 47 0.4× 122 1.2× 50 0.5× 153 1.6× 35 698
Arif Ali China 13 404 1.0× 69 0.6× 297 2.8× 46 0.4× 46 0.5× 24 747
Mark Laws United Kingdom 8 182 0.5× 32 0.3× 77 0.7× 95 0.9× 74 0.8× 12 518
Lalitha Guruprasad India 14 263 0.7× 45 0.4× 233 2.2× 23 0.2× 84 0.9× 43 624
Md Fulbabu Sk India 14 305 0.8× 88 0.8× 129 1.2× 30 0.3× 46 0.5× 32 587
David L. Evers United States 17 350 0.9× 91 0.8× 68 0.6× 29 0.3× 75 0.8× 28 766
Herwig Jansen Germany 14 251 0.6× 38 0.3× 45 0.4× 40 0.4× 63 0.6× 15 669

Countries citing papers authored by Ardavan Abiri

Since Specialization
Citations

This map shows the geographic impact of Ardavan Abiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ardavan Abiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ardavan Abiri more than expected).

Fields of papers citing papers by Ardavan Abiri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ardavan Abiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ardavan Abiri. The network helps show where Ardavan Abiri may publish in the future.

Co-authorship network of co-authors of Ardavan Abiri

This figure shows the co-authorship network connecting the top 25 collaborators of Ardavan Abiri. A scholar is included among the top collaborators of Ardavan Abiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ardavan Abiri. Ardavan Abiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Banazadeh, Mohammad, et al.. (2024). Unexplored power of CRISPR-Cas9 in neuroscience, a multi-OMICs review. International Journal of Biological Macromolecules. 263(Pt 2). 130413–130413. 6 indexed citations
2.
Abiri, Ardavan, et al.. (2024). Phenoxyalkyl cyclic and acyclic amine derivatives: what do they teach us about scaffold-based drug design?. Medicinal Chemistry Research. 33(5). 703–720. 2 indexed citations
3.
Behnam, Behzad, Ahad Mokhtarzadeh, Ramin Rezaee, et al.. (2023). Reproductive Toxicity of Nanoparticles: A Comprehensive Review. Current Medicinal Chemistry. 32(8). 1507–1552. 5 indexed citations
4.
Mirzaei, Mohammad, Iraj Sharifi, Marzieh Anjomshoa, et al.. (2023). Antileishmanial effects and drugability characteristics of a heterocyclic copper complex: An in silico, in vitro and molecular study. Journal of Inorganic Biochemistry. 245. 112245–112245. 1 indexed citations
5.
6.
Abiri, Ardavan, et al.. (2022). A Review on Phosphodiesterase-5 Inhibitors as a Topical Therapy for Erectile Dysfunction. Sexual Medicine Reviews. 10(3). 376–391. 14 indexed citations
7.
Abiri, Ardavan, et al.. (2021). Unlocking G-Quadruplexes as Antiviral Targets. Pharmacological Reviews. 73(3). 897–923. 74 indexed citations
8.
Abiri, Ardavan, et al.. (2021). Discovery of new TLR7 agonists by a combination of statistical learning-based QSAR, virtual screening, and molecular dynamics. Informatics in Medicine Unlocked. 27. 100787–100787. 2 indexed citations
9.
Abiri, Ardavan, et al.. (2020). Refining our methodologies for assessing quadruplex DNA ligands; selectivity or an illusion of selectivity?. Analytical Biochemistry. 613. 113744–113744. 3 indexed citations
10.
Mobini, Gholam Reza, et al.. (2020). Synthetic biology in various cellular and molecular fields: applications, limitations, and perspective. Molecular Biology Reports. 47(8). 6207–6216. 4 indexed citations
11.
Farsimadan, Marziye, et al.. (2020). Association of oestrogen receptor alpha gene SNPs Arg157Ter C>T and Val364Glu T>A with female infertility. British Journal of Biomedical Science. 77(4). 216–218. 9 indexed citations
12.
Moshafi, Mohammad Hassan, et al.. (2020). The art of suicidal molecular seduction for targeting drug resistance. Medical Hypotheses. 140. 109676–109676. 2 indexed citations
13.
Pourshojaei, Yaghoub, Ardavan Abiri, Khalil Eskandari, et al.. (2019). Phenoxyethyl Piperidine/Morpholine Derivatives as PAS and CAS Inhibitors of Cholinesterases: Insights for Future Drug Design. Scientific Reports. 9(1). 19855–19855. 78 indexed citations
14.
15.
16.
Kaboli, Parham Jabbarzadeh, Ardavan Abiri, Mingxing Li, et al.. (2019). Targets and mechanisms of sulforaphane derivatives obtained from cruciferous plants with special focus on breast cancer – contradictory effects and future perspectives. Biomedicine & Pharmacotherapy. 121. 109635–109635. 55 indexed citations
17.
Abiri, Ardavan, et al.. (2019). Eschatological scrutiny of unprofessional usage of molecular docking; how unreliability in computational methods arises from amateurish mistakes. Biocatalysis and Agricultural Biotechnology. 20. 101224–101224. 3 indexed citations
18.
Pourshojaei, Yaghoub, Khalil Eskandari, Maryam Mohammadi‐Khanaposhtani, et al.. (2019). Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti‐Alzheimer's agents. Archiv der Pharmazie. 352(7). e1800352–e1800352. 16 indexed citations
19.
Pourshojaei, Yaghoub, et al.. (2019). Synthesis, biological evaluation, and computational studies of novel fused six-membered O-containing heterocycles as potential acetylcholinesterase inhibitors. Computational Biology and Chemistry. 80. 249–258. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noor Rahman Breakdown of academic impact, for papers by Qingbo Liu Breakdown of academic impact, for papers by Muhammad Junaid Breakdown of academic impact, for papers by Priyanka Shah Breakdown of academic impact, for papers by Arif Ali Breakdown of academic impact, for papers by Mark Laws Breakdown of academic impact, for papers by Lalitha Guruprasad Breakdown of academic impact, for papers by Md Fulbabu Sk Breakdown of academic impact, for papers by David L. Evers Breakdown of academic impact, for papers by Herwig Jansen
Rankless by CCL
2026